NSG 100 Pharmacology, Mobility, Tissue
Latest NSG 100 Pharmacology, Mobility, Tissue (Answer Guide)
Study online at https://quizlet.com/_c96iim
1. 1. Pharmacokinetics factors _______, a. Half-life
________, ________, ________ b. Onset
c. Peak
d. Trough
2. 1. What is the study of physiochemi- c. Pharmacodynamics
cal properties of drugs and how they
influence the body called?
a. Pharmaceutics
b. Pharmacokinetics
c. Pharmacodynamics
d. Pharmacotherapeutics
3. What is The science of preparing and a. Pharmaceutics
dispensing drugs, including dosage
form design; The study of how various
drug forms influence the way in which
the drug affects the body?
a. Pharmaceutics
b. Pharmacokinetics
c. Pharmacodynamics
d. Pharmacotherapeutics
4. what is The treatment of pathologic d. Pharmacotherapeutics
conditions through the use of drugs?
a. Pharmaceutics
b. Pharmacokinetics
c. Pharmacodynamics
d. Pharmacotherapeutics
5. what is The study of what the body b. Pharmacokinetics
does to the drug. The study of what
[2026] Page 1 of 59
, NSG 100 Pharmacology, Mobility, Tissue
Latest NSG 100 Pharmacology, Mobility, Tissue (Answer Guide)
Study online at https://quizlet.com/_c96iim
happens to a drug from the time it
is put into the body until the par-
ent drug and all metabolites have left
the body. Pharmacokinetics represent
the drug absorption into, distribution
and metabolism within, and excretion
from the body?
a. Pharmaceutics
b. Pharmacokinetics
c. Pharmacodynamics
d. Pharmacotherapeutics
6. 1. A patient asks the nurse the dif- b. Have the same chemical composition as the
ference between a generic drug and brand-name drug
a trade or brand-name drug. Which c. May have several brand names
of the following are true regarding e. Are usually less expensive than a brand-name
generic drugs? Select all that apply drug
a. Have less potential for abuse and
dependence * Generic and trade or brand-name drugs have
b. Have the same chemical composi- the same chemical composition and the same ef-
tion as the brand-name drug fects, Generic drugs are usually less expensive.
c. May have several brand names Each drug has only one generic name. The trade
d. My have several generic names name is the brand of proprietary name given by
e. Are usually less expensive than a the manufacturer; various manufacturers give the
brand-name drug drug different brand names. There is no differ-
ence in abuse potential between a generic and
brand-name drug.
7. 1. Patients with renal failure would a. Excretion
most likely have problems with which
pharmacokinetics process? * The kidneys are responsible for the majority of
a. Excretion
[2026] Page 2 of 59
, NSG 100 Pharmacology, Mobility, Tissue
Latest NSG 100 Pharmacology, Mobility, Tissue (Answer Guide)
Study online at https://quizlet.com/_c96iim
b. Absorption drug excretion. A patient with renal failure would
c. Metabolism have a difficult time with drug excretion.
d. Distribution
8. 1. A staff educator is preparing an c. Liver failure
in-service to review factors that influ-
ence medication metabolism. Which e. Concurrent use of medication with the same
of the following would the educator pathway of metabolism
include as a reason to administer a
* Rationale: Increased renal excretion and In-
lower medication dosage? Select all
creased medication-metabolizing enzymes de-
that apply
crease the concentration of the medication, poten-
a. Increased renal excretion
tially requiring increased strength. Liver failure de-
b. Increased medication-metaboliz-
creases metabolism, thus increasing the concen-
ing enzymes
tration of a medication. This requires decreasing
c. Liver failure
the dosage. Peripheral vascular disease impairs
d. Peripheral vascular disease
distribution, may require an increased dose. When
e. Concurrent use of medication with
the same pathway metabolizes two medications,
the same pathway of metabolism
they compete for metabolism, potentially increas-
ing the concentration of one or both medications.
Requiring deceasing the dose of one or both med-
ications
9. 1. A patient asks the nurse why a low- b. Medications given intravenously are not affected
er dose of IV pain medication is be- by the first-pass effect
ing given than the previous oral dose.
What is the nurses best response to * Rationale: When drugs with a high first-pass
the patient? effect are administered orally, a large amount of
a. Medications given orally bypass the drug may be metabolized before it reaches the
portal circulatory system systemic circulation. The same drug given IV will
b. Medications given intravenously bypass the liver. This prevents the first-pass effect
are not affected by the first-pass ef- from taking place, and therefore more of the drug
reaches the circulation. Parenteral doses of drugs
[2026] Page 3 of 59
, NSG 100 Pharmacology, Mobility, Tissue
Latest NSG 100 Pharmacology, Mobility, Tissue (Answer Guide)
Study online at https://quizlet.com/_c96iim
fect with a high first-pass effect are much smaller than
c. Drugs administered intravenously oral doses, yet they produce the same pharmaco-
enter the portal system before sys- logic response.
temic distribution
d. A large percentage of an intra-
venously administered drug is metab-
olized into inactive metabolites in the
liver
10. 1. A patient is prescribed ibuprofen b. Call the pharmacy and ask for the liquid form of
200 mg PO every 4 hours as need- the medication
ed for pain. The pharmacy sends up
enteric-coated tablets, but the patient * The liquid form is appropriate because it is
refuses the tablets, stating that she also given via the oral route. Enteric-coated tablets
cannot swallow pills. What will the should not be crushed, and the patient should
nurse do? not be forced to take the tablets. This medication
a. Crush the tablets and mix them does not have an IV form, but even if it did, the
with applesauce or pudding routes cannot be changed without a health care
b. Call the pharmacy and ask for the provider's order.
liquid form of the medication
c. Call the pharmacy and ask for the IV
form of the medication
d. Encourage the patient to try to
swallow the tablets
11. what does the FDA do? * Responsible for approving drugs for clinical safe-
ty and efficacy before they are brought to market.
12. what does the DEA do? responsible for enforcing the controlled sub-
stances laws and regulations of the United States
13. what does the controlled substance
act do?
[2026] Page 4 of 59
Latest NSG 100 Pharmacology, Mobility, Tissue (Answer Guide)
Study online at https://quizlet.com/_c96iim
1. 1. Pharmacokinetics factors _______, a. Half-life
________, ________, ________ b. Onset
c. Peak
d. Trough
2. 1. What is the study of physiochemi- c. Pharmacodynamics
cal properties of drugs and how they
influence the body called?
a. Pharmaceutics
b. Pharmacokinetics
c. Pharmacodynamics
d. Pharmacotherapeutics
3. What is The science of preparing and a. Pharmaceutics
dispensing drugs, including dosage
form design; The study of how various
drug forms influence the way in which
the drug affects the body?
a. Pharmaceutics
b. Pharmacokinetics
c. Pharmacodynamics
d. Pharmacotherapeutics
4. what is The treatment of pathologic d. Pharmacotherapeutics
conditions through the use of drugs?
a. Pharmaceutics
b. Pharmacokinetics
c. Pharmacodynamics
d. Pharmacotherapeutics
5. what is The study of what the body b. Pharmacokinetics
does to the drug. The study of what
[2026] Page 1 of 59
, NSG 100 Pharmacology, Mobility, Tissue
Latest NSG 100 Pharmacology, Mobility, Tissue (Answer Guide)
Study online at https://quizlet.com/_c96iim
happens to a drug from the time it
is put into the body until the par-
ent drug and all metabolites have left
the body. Pharmacokinetics represent
the drug absorption into, distribution
and metabolism within, and excretion
from the body?
a. Pharmaceutics
b. Pharmacokinetics
c. Pharmacodynamics
d. Pharmacotherapeutics
6. 1. A patient asks the nurse the dif- b. Have the same chemical composition as the
ference between a generic drug and brand-name drug
a trade or brand-name drug. Which c. May have several brand names
of the following are true regarding e. Are usually less expensive than a brand-name
generic drugs? Select all that apply drug
a. Have less potential for abuse and
dependence * Generic and trade or brand-name drugs have
b. Have the same chemical composi- the same chemical composition and the same ef-
tion as the brand-name drug fects, Generic drugs are usually less expensive.
c. May have several brand names Each drug has only one generic name. The trade
d. My have several generic names name is the brand of proprietary name given by
e. Are usually less expensive than a the manufacturer; various manufacturers give the
brand-name drug drug different brand names. There is no differ-
ence in abuse potential between a generic and
brand-name drug.
7. 1. Patients with renal failure would a. Excretion
most likely have problems with which
pharmacokinetics process? * The kidneys are responsible for the majority of
a. Excretion
[2026] Page 2 of 59
, NSG 100 Pharmacology, Mobility, Tissue
Latest NSG 100 Pharmacology, Mobility, Tissue (Answer Guide)
Study online at https://quizlet.com/_c96iim
b. Absorption drug excretion. A patient with renal failure would
c. Metabolism have a difficult time with drug excretion.
d. Distribution
8. 1. A staff educator is preparing an c. Liver failure
in-service to review factors that influ-
ence medication metabolism. Which e. Concurrent use of medication with the same
of the following would the educator pathway of metabolism
include as a reason to administer a
* Rationale: Increased renal excretion and In-
lower medication dosage? Select all
creased medication-metabolizing enzymes de-
that apply
crease the concentration of the medication, poten-
a. Increased renal excretion
tially requiring increased strength. Liver failure de-
b. Increased medication-metaboliz-
creases metabolism, thus increasing the concen-
ing enzymes
tration of a medication. This requires decreasing
c. Liver failure
the dosage. Peripheral vascular disease impairs
d. Peripheral vascular disease
distribution, may require an increased dose. When
e. Concurrent use of medication with
the same pathway metabolizes two medications,
the same pathway of metabolism
they compete for metabolism, potentially increas-
ing the concentration of one or both medications.
Requiring deceasing the dose of one or both med-
ications
9. 1. A patient asks the nurse why a low- b. Medications given intravenously are not affected
er dose of IV pain medication is be- by the first-pass effect
ing given than the previous oral dose.
What is the nurses best response to * Rationale: When drugs with a high first-pass
the patient? effect are administered orally, a large amount of
a. Medications given orally bypass the drug may be metabolized before it reaches the
portal circulatory system systemic circulation. The same drug given IV will
b. Medications given intravenously bypass the liver. This prevents the first-pass effect
are not affected by the first-pass ef- from taking place, and therefore more of the drug
reaches the circulation. Parenteral doses of drugs
[2026] Page 3 of 59
, NSG 100 Pharmacology, Mobility, Tissue
Latest NSG 100 Pharmacology, Mobility, Tissue (Answer Guide)
Study online at https://quizlet.com/_c96iim
fect with a high first-pass effect are much smaller than
c. Drugs administered intravenously oral doses, yet they produce the same pharmaco-
enter the portal system before sys- logic response.
temic distribution
d. A large percentage of an intra-
venously administered drug is metab-
olized into inactive metabolites in the
liver
10. 1. A patient is prescribed ibuprofen b. Call the pharmacy and ask for the liquid form of
200 mg PO every 4 hours as need- the medication
ed for pain. The pharmacy sends up
enteric-coated tablets, but the patient * The liquid form is appropriate because it is
refuses the tablets, stating that she also given via the oral route. Enteric-coated tablets
cannot swallow pills. What will the should not be crushed, and the patient should
nurse do? not be forced to take the tablets. This medication
a. Crush the tablets and mix them does not have an IV form, but even if it did, the
with applesauce or pudding routes cannot be changed without a health care
b. Call the pharmacy and ask for the provider's order.
liquid form of the medication
c. Call the pharmacy and ask for the IV
form of the medication
d. Encourage the patient to try to
swallow the tablets
11. what does the FDA do? * Responsible for approving drugs for clinical safe-
ty and efficacy before they are brought to market.
12. what does the DEA do? responsible for enforcing the controlled sub-
stances laws and regulations of the United States
13. what does the controlled substance
act do?
[2026] Page 4 of 59
